Synerise Secures $8.5M in Series B+ Funding to Advance AI-Driven Behavioral Modeling
Synerise is not only a leader in commercial AI and big data solutions but also contributes to open-source projects that assist in developing cancer drugs and generic medications.
Company Name: Synerise
Location: Krakow, Poland
Sector: Technology, Artificial Intelligence, Big Data
Funding Details: Raised $8.5M in Series B+ funding led by VTEX.
Purpose of Investment: To expand into new markets and strengthen its position as a global leader in behavioral AI.
Leadership: Founded and led by CEO Jaroslaw Królewski.
Product: Synerise provides a deep-tech SaaS platform that utilizes advanced AI and big data technologies to enable organizations to store, process, and analyze data in real-time. The platform is designed to personalize user experiences, predict future trends, and optimize business operations. Synerise supports over 1 billion AI-driven autonomous decisions daily and operates in more than 150 markets.
About Company: Synerise is not only a leader in commercial AI and big data solutions but also contributes to open-source projects that assist in developing cancer drugs and generic medications. The company is deeply invested in supporting educational programs, scientific research, and community initiatives. With offices in Warsaw, San Francisco, and Dubai, Synerise is well-positioned to advance its global reach and impact, enhancing its capabilities to meet the evolving needs of industries worldwide. This funding will enable further technological innovations and market expansion efforts.